New drug combo offers hope for Hard-to-Treat lymphoma
NCT ID NCT04572763
First seen Jan 09, 2026 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This study is testing whether combining two drugs, copanlisib and venetoclax, can help people with a type of blood cancer called diffuse large B-cell lymphoma that has come back or not responded to prior treatments. About 48 adults will take part. The goal is to find the safest dose and see how many patients' tumors shrink or disappear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Cancer Center
Duarte, California, 91010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Siteman Cancer Center at Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.